Roy W. Ware, PhD, MBA appointed as Chief Manufacturing and Technology OfficerCaryn Barnett appointed as VP, Clinical OperationsPablo Lee, MD, MBA, appointed as VP, Medical Affairs  CAMBRIDGE, United Kingdom and NEW YORK, February 16, 2026 – Artios Pharma Limited (“Artios”), a clinical-stage biopharmaceutical company pioneering the development of new classes of DNA Damage Response (DDR) medicines to deliver meaningful survival benefits for patients with cancer, today announced the appointment of three senior ...